Bulletin
Investor Alert

London Markets Open in:

AbbVie Inc.

NYS: ABBV

GO
/marketstate/country/us

After Hours

/zigman2/quotes/202428675/composite

$

85.04

Change

-0.38 -0.44%

Volume

Volume 391,840

Feb 27, 2020, 7:53 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202428675/composite

Previous close

$ 88.41

$ 85.42

Change

-2.99 -3.38%

Day low

Day high

$84.20

$89.45

Open
Open: 86.19

52 week low

52 week high

$62.66

$97.86

Open

Market cap

$130.77B

Average volume

9.03M

P/E ratio

16.17

Rev. per Employee

$1.09M

EPS

5.28

Dividend

1.18

Div yield

5.53%

Ex dividend date

4/14/20

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/abbv

MarketWatch News on ABBV

  1. Here are 25 Dividend Aristocrat stocks screened for ‘quality’

    8:55 a.m. Feb. 22, 2020

    - Philip van Doorn

  2. Stocks end lower as market retreats from records

    4:22 p.m. Feb. 7, 2020

    - Mark DeCambre

  3. AbbVie Jumps on Strong Earnings. That’s Not the Only Reason.

    9:33 a.m. Feb. 7, 2020

    - Josh Nathan-Kazis

  4. AbbVie's stock rises on strong earnings

    8:10 a.m. Feb. 7, 2020

    - Jaimy Lee

  5. AbbVie stock jumps 2.6% premarket

    7:48 a.m. Feb. 7, 2020

    - Ciara Linnane

  6. AbbVie Q1 FactSet EPS consensus $2.12; 2020 consensus $9.45

    7:48 a.m. Feb. 7, 2020

    - Ciara Linnane

  7. AbbVie now sees Q1 adj. EPS $2.28 to $2.30

    7:47 a.m. Feb. 7, 2020

    - Ciara Linnane

  8. AbbVie now sees 2020 EPS $7.66 to $7.76; adj. EPS $9.61 to $9.71

    7:46 a.m. Feb. 7, 2020

    - Ciara Linnane

  9. AbbVie Q4 revenue $8.704 bln vs. $8.305 bln; FactSet consensus $8.692 bln

    7:46 a.m. Feb. 7, 2020

    - Ciara Linnane

  10. AbbVie Q4 adj. EPS $2.21; FactSet consensus $2.19

    7:45 a.m. Feb. 7, 2020

    - Ciara Linnane

  11. AbbVie Q4 EPS $1.88 vs. loss per share $1.23

    7:45 a.m. Feb. 7, 2020

    - Ciara Linnane

  12. Alphabet, Uber, Disney and Other Stocks to Watch This Week

    3:00 p.m. Feb. 2, 2020

    - Nicholas Jasinski

  13. 3 Biotech Stocks Are Soaring. Everyone Wants a Coronavirus Vaccine.

    4:42 p.m. Jan. 27, 2020

    - Josh Nathan-Kazis

  14. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/abbv

Other News on ABBV

  1. Healthcare Faces A Contagion

    9:36 a.m. Feb. 27, 2020

    - Seeking Alpha

  2. Big Pharma Scares Off Short Sellers

    8:01 a.m. Feb. 27, 2020

    - 247WallSt.com

  3. RRSP Deadline - March 2nd; New Purchases

    12:42 a.m. Feb. 26, 2020

    - Seeking Alpha

  4. RBC Capital Reaffirms Their Hold Rating on AbbVie (ABBV)

    4:41 a.m. Feb. 25, 2020

    - SmarterAnalyst

  5. 10-K: ABBVIE INC.

    10:54 a.m. Feb. 21, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  6. Dems attack Trump over stalled efforts to lower drug prices

    9:32 a.m. Feb. 21, 2020

    - Seeking Alpha

  7. CoolTone competitor sues Allergan over "false" advertising

    1:14 p.m. Feb. 20, 2020

    - Seeking Alpha

  8. David Abrams Buys 2 Stocks in 4th Quarter

    11:37 a.m. Feb. 20, 2020

    - GuruFocus.com

  9. One of Your Stock Investments is Being Acquired: Now What?

    10:23 a.m. Feb. 20, 2020

    - Zacks.com

  10. Loading more headlines...
/news/pressrelease/company/us/abbv

Press Releases on ABBV

  1. Double Barreled Antibodies Drug analysis by stage of development

    7:12 a.m. Feb. 27, 2020

    - HTF Market Intelligence

  2. Summit Appoints Robert W. Duggan as Executive Chairman

    7:00 a.m. Feb. 26, 2020

    - GlobeNewswire

  3. AbbVie Inc. - Rule 2.10 Announcement - Relevant Securities in Issue

    6:00 a.m. Feb. 25, 2020

    - PR Newswire - PRF

  4. Loading more headlines...

Rates »

Link to MarketWatch's Slice.